biocompatible gold nanorod
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
-
Jack Lifton interviews David Regan of Sona Nanotech on its breakthrough, gold nanorod, medical technology
In a recent InvestorIntel interview, Jack Lifton spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA…
